CNTB: Connect Biopharma Holdings Limited - American Depositary Shares

2.10 USD 0.26 (14.13%)

Settore: Salute Base: US Dollar Valuta di profitto: US Dollar

Il tasso di cambio CNTB ha avuto una variazione del 14.13% per oggi. Durante la giornata, lo strumento è stato scambiato ad un minimo di 1.73 e ad un massimo di 2.11.

Segui le dinamiche di Connect Biopharma Holdings Limited - American Depositary Shares. Le quotazioni in tempo reale aiutano a reagire velocemente alle variazioni di mercato. Scorrendo tra i diversi timeframe, è possibile monitorare le tendenze e le dinamiche dei tassi di cambio di minuti, ore, giorni, settimane e mesi. Utilizza queste informazioni per prevedere i cambiamenti del mercato e prendere decisioni di trading consapevoli.

Grafico a schermo intero

CNTB News

Zacks 16:00 What Makes Connect Biopharma Holdings Limited Sponsored ADR (CNTB) a Strong Momentum Stock: Buy Now?
Investing 13:45 Connect Biopharma stock rating reiterated as Outperform by Northland
Investing 13:32 Connect Biopharma appoints Jim Schoeneck to board of directors
Investing 13:17 Connect Biopharma appoints James A. Schoeneck to board of directors
Investing 13:52 Connect Biopharma stock rises after announcing plan to terminate ADR program
Investing 13:16 Connect Biopharma to terminate ADR program, list ordinary shares
Investing 13:31 Connect Biopharma regains Nasdaq compliance with minimum bid price rule
Investing 13:07 Connect Biopharma regains Nasdaq compliance with $1 minimum bid price
Investing 13:13 Connect Biopharma’s partner submits new drug application in China
Investing 13:05 Connect Biopharma reports positive data for asthma treatment
Investing 13:52 Connect Biopharma Announces Two Oral Presentations at the European Academy of Allergy and Clinical Immunology (EAACI) 2025 Annual Congress
Investing 13:40 Connect Biopharma to Present at Two Upcoming Investor Conferences in June
Investing 13:32 Connect Biopharma Presents Data Supporting Development of Rademikibart at the American Thoracic Society (ATS) 2025 International Conference
Investing 13:52 Connect Biopharma Reports First Quarter 2025 Financial Results and Provides Business Update
Investing 13:27 Connect Biopharma Initiates Phase 2 Seabreeze STAT COPD Study Evaluating Rademikibart for the Treatment of Acute Exacerbations in COPD

Intervallo Giornaliero

1.73 2.11

Intervallo Annuale

0.51 2.86

Chiusura Precedente: 1.75
Apertura: 1.84

Bid: 2.10
Ask: 2.40

Minimo: 1.73
Massimo: 2.11

Volume: 450

Variazione giornaliera: 14.13%
Variazione Mensile: 101.92%

Variazione Semestrale: 116.49%
Variazione Annuale: 77.97%

31 luglio, giovedì